224 related articles for article (PubMed ID: 30290085)
21. [Gene mutation and myelodysplastic syndromes with ring sideroblast excess].
Meng FK; Huang LF; Zhou JF; Sun HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1088-90. PubMed ID: 23998618
[TBL] [Abstract][Full Text] [Related]
22. [Dyserythropoiesis in myelodysplastic syndrome].
Iwama A
Rinsho Ketsueki; 2018; 59(10):2036-2041. PubMed ID: 30305506
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of reticulocyte maturation parameters in the differential diagnosis of macrocytic anemias].
Kim MH
Korean J Lab Med; 2007 Feb; 27(1):13-8. PubMed ID: 18094544
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology.
Gowanlock Z; Sriram S; Martin A; Xenocostas A; Lazo-Langner A
PLoS One; 2016; 11(6):e0157279. PubMed ID: 27310832
[TBL] [Abstract][Full Text] [Related]
25. The Frequency of SF3B1 Mutations in Thai Patients with Myelodysplastic Syndrome.
Rujirachaivej P; Siriboonpiputtana T; Rerkamnuaychoke B; Magmuang S; Chareonsirisuthigul T; Boonsakan P; Petvises S; Sirirat T; Niparuck P; Chuncharunee S
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1825-1831. PubMed ID: 30049194
[TBL] [Abstract][Full Text] [Related]
26. The Molecular Pathology of Myelodysplastic Syndrome.
Haferlach T
Pathobiology; 2019; 86(1):24-29. PubMed ID: 29791902
[TBL] [Abstract][Full Text] [Related]
27. Refractory anemia with ring sideroblasts and RARS with thrombocytosis.
Patnaik MM; Tefferi A
Am J Hematol; 2015 Jun; 90(6):549-59. PubMed ID: 25899435
[TBL] [Abstract][Full Text] [Related]
28. The relation of SF3B1 mutation and intracellular iron in myelodysplastic syndrome with less than 5% bone marrow blasts.
Ma L; Luo Y; Jiang L; Shen D; Li J; Xu W; Mei C; Zhou X; Ren Y; Ye L; Lu C; Jie J; Tong H
Leuk Lymphoma; 2019 May; 60(5):1179-1186. PubMed ID: 30409066
[TBL] [Abstract][Full Text] [Related]
29. [Significance of somatic mutations on the prognosis of myelodysplastic syndromes].
Yoshizato T
Rinsho Ketsueki; 2018; 59(8):1078-1085. PubMed ID: 30185709
[TBL] [Abstract][Full Text] [Related]
30. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification].
Wang XQ;
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053
[TBL] [Abstract][Full Text] [Related]
31. Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes.
Foran JM; Shammo JM
Am J Med; 2012 Jul; 125(7 Suppl):S6-13. PubMed ID: 22735753
[TBL] [Abstract][Full Text] [Related]
32. Splicing factor mutations in MDS RARS and MDS/MPN-RS-T.
Yoshimi A; Abdel-Wahab O
Int J Hematol; 2017 Jun; 105(6):720-731. PubMed ID: 28466384
[TBL] [Abstract][Full Text] [Related]
33. [Concurrent CALR and SF3B1 gene mutations in a patient with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis].
Nakao K; Oka S; Utsumi T; Yamada S; Kondo T; Tohyama K; Asagoe K
Rinsho Ketsueki; 2019; 60(8):915-919. PubMed ID: 31484889
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of SF3B1 Mutation Screening by High-Resolution Melting Analysis and its Clinical Utility for Myelodysplastic Syndrome with Ring Sideroblasts at the Point of Diagnosis.
Mizuta S; Yamane N; Komai T; Koba Y; Ukyo N; Tamekane A; Watanabe M
Lab Med; 2019 Jul; 50(3):254-262. PubMed ID: 30590617
[TBL] [Abstract][Full Text] [Related]
35. SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.
Lin CC; Hou HA; Chou WC; Kuo YY; Wu SJ; Liu CY; Chen CY; Tseng MH; Huang CF; Lee FY; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Hsu SC; Ko BS; Tsay W; Chen YC; Tien HF
Am J Hematol; 2014 Aug; 89(8):E109-15. PubMed ID: 24723457
[TBL] [Abstract][Full Text] [Related]
36. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
[TBL] [Abstract][Full Text] [Related]
37. Unexplained macrocytosis in elderly patients.
Mahmoud MY; Lugon M; Anderson CC
Age Ageing; 1996 Jul; 25(4):310-2. PubMed ID: 8831877
[TBL] [Abstract][Full Text] [Related]
38. Comparison of SF3B1/DNMT3A Comutations With DNMT3A or SF3B1 Mutation Alone in Myelodysplastic Syndrome and Clonal Cytopenia of Undetermined Significance.
Song J; Hussaini M; Qin D; Zhang X; Shao H; Zhang L; Gajzer D; Basra P; Moscinski L; Zhang H
Am J Clin Pathol; 2020 Jun; 154(1):48-56. PubMed ID: 32112088
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of pre-myelodysplastic syndromes blood values correlate with disease risk and survival.
Joffe E; Greenbaum U; Man-El G; Filanovsky K; Oster HS; Levi I; Raanani P; Avivi I; Mittelman M
Hematol Oncol; 2020 Dec; 38(5):782-791. PubMed ID: 32632931
[TBL] [Abstract][Full Text] [Related]
40. Hemorrhagic risk due to platelet dysfunction in myelodysplastic patients, correlations with anemia severity and iron overload.
Popov VM; Vladareanu AM; Bumbea H; Kovacs E; Savopol T; Iordache MM; Moisescu MG
Blood Coagul Fibrinolysis; 2015 Oct; 26(7):743-9. PubMed ID: 25811447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
